 | • レポートコード：QYR9NV18472 • 出版社/出版日：QYResearch / 2019年11月18日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品・ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、遅発性ジスキネジア（TD）治療薬の世界市場について調査・分析し、遅発性ジスキネジア（TD）治療薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（バルベナジン、デュテトラナジン）、用途別（病院、診療所、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の遅発性ジスキネジア（TD）治療薬市場動向 ・主要企業別マーケットシェア ・遅発性ジスキネジア（TD）治療薬の種類別市場規模2014-2019 （バルベナジン、デュテトラナジン） ・遅発性ジスキネジア（TD）治療薬の用途別市場規模2014-2019 （病院、診療所、その他） ・遅発性ジスキネジア（TD）治療薬の北米市場：主要企業・種類別/用途別市場規模 ・遅発性ジスキネジア（TD）治療薬のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・遅発性ジスキネジア（TD）治療薬の中国市場：主要企業・種類別/用途別市場規模 ・遅発性ジスキネジア（TD）治療薬の日本国内市場：主要企業・種類別/用途別市場規模 ・遅発性ジスキネジア（TD）治療薬の東南アジア市場：主要企業・種類別/用途別市場規模 ・遅発性ジスキネジア（TD）治療薬のインド市場：主要企業・種類別/用途別市場規模 ・遅発性ジスキネジア（TD）治療薬の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Neurocrine Biosciences, Inc.、Teva Pharmaceutical Industries、Pfizer Inc.、Biogen、Novartis AG、AstraZeneca、GlaxoSmithKline plc.、Bayer AG、Sanofi） ・遅発性ジスキネジア（TD）治療薬の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Tardive dyskinesia is a type of neurological disorder, which characterized the blink your eyes fast, chew, smack or pucker of lips, puff out your cheeks, tongue and others. The patients treating with neuroleptic drugs or anti-psychotic medications can also be the cause of tardive dyskinesia. Tardive dyskinesia is difficult to treat as treatment process is also not confirmed and the drug is also not approved in various conditions. The treatment of tardive dyskinesia is directly affect the neurological system of the respective patients. This disorder may commonly occurs in smoker than non-smoker, and also in the patient of depression, anxiety disorder and others.In 2018, the global Tardive Dyskinesia (TD) Treatment Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Tardive Dyskinesia (TD) Treatment Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Tardive Dyskinesia (TD) Treatment Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
Neurocrine Biosciences, Inc.
Teva Pharmaceutical Industries
Pfizer Inc.
Biogen
Novartis AG
AstraZeneca
GlaxoSmithKline plc.
Bayer AG
Sanofi
Market segment by Type, the product can be split into
Valbenazine
Deutetrabenazine
Market segment by Application, split into
Hospitals
Clinic
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Tardive Dyskinesia (TD) Treatment Drugs status, future forecast, growth opportunity, key market and key players.
To present the Tardive Dyskinesia (TD) Treatment Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Tardive Dyskinesia (TD) Treatment Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Tardive Dyskinesia (TD) Treatment Drugs Market Size Growth Rate by Type (2014-2025)
1.4.2 Valbenazine
1.4.3 Deutetrabenazine
1.5 Market by Application
1.5.1 Global Tardive Dyskinesia (TD) Treatment Drugs Market Share by Application (2019-2025)
1.5.2 Hospitals
1.5.3 Clinic
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Tardive Dyskinesia (TD) Treatment Drugs Market Size
2.2 Tardive Dyskinesia (TD) Treatment Drugs Growth Trends by Regions
2.2.1 Tardive Dyskinesia (TD) Treatment Drugs Market Size by Regions (2019-2025)
2.2.2 Tardive Dyskinesia (TD) Treatment Drugs Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
3 Market Share by Key Players
3.1 Tardive Dyskinesia (TD) Treatment Drugs Market Size by by Players
3.1.1 Global Tardive Dyskinesia (TD) Treatment Drugs Revenue by by Players (2014-2019)
3.1.2 Global Tardive Dyskinesia (TD) Treatment Drugs Revenue Market Share by by Players (2014-2019)
3.1.3 Global Tardive Dyskinesia (TD) Treatment Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Tardive Dyskinesia (TD) Treatment Drugs Key Players Head office and Area Served
3.3 Key Players Tardive Dyskinesia (TD) Treatment Drugs Product/Solution/Service
3.4 Date of Enter into Tardive Dyskinesia (TD) Treatment Drugs Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type (2014-2019)
4.2 Global Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application (2014-2019)
5 North America
5.1 North America Tardive Dyskinesia (TD) Treatment Drugs Market Size (2014-2019)
5.2 Tardive Dyskinesia (TD) Treatment Drugs Key Players in North America
5.3 North America Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type
5.4 North America Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application
6 Europe
6.1 Europe Tardive Dyskinesia (TD) Treatment Drugs Market Size (2014-2019)
6.2 Tardive Dyskinesia (TD) Treatment Drugs Key Players in Europe
6.3 Europe Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type
6.4 Europe Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application
7 China
7.1 China Tardive Dyskinesia (TD) Treatment Drugs Market Size (2014-2019)
7.2 Tardive Dyskinesia (TD) Treatment Drugs Key Players in China
7.3 China Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type
7.4 China Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application
8 Japan
8.1 Japan Tardive Dyskinesia (TD) Treatment Drugs Market Size (2014-2019)
8.2 Tardive Dyskinesia (TD) Treatment Drugs Key Players in Japan
8.3 Japan Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type
8.4 Japan Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Tardive Dyskinesia (TD) Treatment Drugs Market Size (2014-2019)
9.2 Tardive Dyskinesia (TD) Treatment Drugs Key Players in Southeast Asia
9.3 Southeast Asia Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type
9.4 Southeast Asia Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application
10 India
10.1 India Tardive Dyskinesia (TD) Treatment Drugs Market Size (2014-2019)
10.2 Tardive Dyskinesia (TD) Treatment Drugs Key Players in India
10.3 India Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type
10.4 India Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application
11 Central & South America
11.1 Central & South America Tardive Dyskinesia (TD) Treatment Drugs Market Size (2014-2019)
11.2 Tardive Dyskinesia (TD) Treatment Drugs Key Players in Central & South America
11.3 Central & South America Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type
11.4 Central & South America Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application
12 International Players Profiles
12.1 Neurocrine Biosciences, Inc.
12.1.1 Neurocrine Biosciences, Inc. Company Details
12.1.2 Company Description and Business Overview
12.1.3 Tardive Dyskinesia (TD) Treatment Drugs Introduction
12.1.4 Neurocrine Biosciences, Inc. Revenue in Tardive Dyskinesia (TD) Treatment Drugs Business (2014-2019))
12.1.5 Neurocrine Biosciences, Inc. Recent Development
12.2 Teva Pharmaceutical Industries
12.2.1 Teva Pharmaceutical Industries Company Details
12.2.2 Company Description and Business Overview
12.2.3 Tardive Dyskinesia (TD) Treatment Drugs Introduction
12.2.4 Teva Pharmaceutical Industries Revenue in Tardive Dyskinesia (TD) Treatment Drugs Business (2014-2019)
12.2.5 Teva Pharmaceutical Industries Recent Development
12.3 Pfizer Inc.
12.3.1 Pfizer Inc. Company Details
12.3.2 Company Description and Business Overview
12.3.3 Tardive Dyskinesia (TD) Treatment Drugs Introduction
12.3.4 Pfizer Inc. Revenue in Tardive Dyskinesia (TD) Treatment Drugs Business (2014-2019)
12.3.5 Pfizer Inc. Recent Development
12.4 Biogen
12.4.1 Biogen Company Details
12.4.2 Company Description and Business Overview
12.4.3 Tardive Dyskinesia (TD) Treatment Drugs Introduction
12.4.4 Biogen Revenue in Tardive Dyskinesia (TD) Treatment Drugs Business (2014-2019)
12.4.5 Biogen Recent Development
12.5 Novartis AG
12.5.1 Novartis AG Company Details
12.5.2 Company Description and Business Overview
12.5.3 Tardive Dyskinesia (TD) Treatment Drugs Introduction
12.5.4 Novartis AG Revenue in Tardive Dyskinesia (TD) Treatment Drugs Business (2014-2019)
12.5.5 Novartis AG Recent Development
12.6 AstraZeneca
12.6.1 AstraZeneca Company Details
12.6.2 Company Description and Business Overview
12.6.3 Tardive Dyskinesia (TD) Treatment Drugs Introduction
12.6.4 AstraZeneca Revenue in Tardive Dyskinesia (TD) Treatment Drugs Business (2014-2019)
12.6.5 AstraZeneca Recent Development
12.7 GlaxoSmithKline plc.
12.7.1 GlaxoSmithKline plc. Company Details
12.7.2 Company Description and Business Overview
12.7.3 Tardive Dyskinesia (TD) Treatment Drugs Introduction
12.7.4 GlaxoSmithKline plc. Revenue in Tardive Dyskinesia (TD) Treatment Drugs Business (2014-2019)
12.7.5 GlaxoSmithKline plc. Recent Development
12.8 Bayer AG
12.8.1 Bayer AG Company Details
12.8.2 Company Description and Business Overview
12.8.3 Tardive Dyskinesia (TD) Treatment Drugs Introduction
12.8.4 Bayer AG Revenue in Tardive Dyskinesia (TD) Treatment Drugs Business (2014-2019)
12.8.5 Bayer AG Recent Development
12.9 Sanofi
12.9.1 Sanofi Company Details
12.9.2 Company Description and Business Overview
12.9.3 Tardive Dyskinesia (TD) Treatment Drugs Introduction
12.9.4 Sanofi Revenue in Tardive Dyskinesia (TD) Treatment Drugs Business (2014-2019)
12.9.5 Sanofi Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Product (2019-2025)
13.2 Market Size Forecast by Application (2019-2025)
13.3 Market Size Forecast by Regions
13.4 North America
13.5 Europe
13.6 China
13.7 Japan
13.8 Southeast Asia
13.9 India
13.10 Central & South America
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Tardive Dyskinesia (TD) Treatment Drugs Key Market Segments
Table Key Players Tardive Dyskinesia (TD) Treatment Drugs Covered
Table Global Tardive Dyskinesia (TD) Treatment Drugs Market Size Growth Rate by Type 2018-2025 (Million US$)
Figuer Valbenazine Figures
Table Key Players of Valbenazine
Figuer Deutetrabenazine Figures
Table Key Players of Deutetrabenazine
Table Global Tardive Dyskinesia (TD) Treatment Drugs Market Size Growth by Application 2019-2025 (Million US$)
Figure Global Tardive Dyskinesia (TD) Treatment Drugs Market Share by Application in 2018 & 2025
Figure Hospitals Case Studies
Figure Clinic Case Studies
Figure Others Case Studies
Figure Tardive Dyskinesia (TD) Treatment Drugs Report Years Considered
Figure Global Tardive Dyskinesia (TD) Treatment Drugs Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Tardive Dyskinesia (TD) Treatment Drugs Market Size by Regions 2019-2025 (Million US$)
Table Global Tardive Dyskinesia (TD) Treatment Drugs Market Size by Regions 2019-2025 (Million US$)
Table Global Tardive Dyskinesia (TD) Treatment Drugs Market Share by Regions 2014-2019
Figure Global Tardive Dyskinesia (TD) Treatment Drugs Market Share by Regions 2014-2019
Figure Global Tardive Dyskinesia (TD) Treatment Drugs Market Share by Regions in 2018
Table Market Top Trends
Table Key Drivers: Impact Analysis (2019-2025)
Table Key Challenges
Figure PORTER'S FIVE FORCES ANALYSIS
Table Global Tardive Dyskinesia (TD) Treatment Drugs Revenue by by Players (2014-2019) (Million US$)
Table Global Tardive Dyskinesia (TD) Treatment Drugs Market Share by by Players (2014-2019)
Figure Global Tardive Dyskinesia (TD) Treatment Drugs Market Share by by Players in 2018
Table Global Tardive Dyskinesia (TD) Treatment Drugs by Players Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Tardive Dyskinesia (TD) Treatment Drugs Product/Solution/Service
Table Date of Enter into Tardive Dyskinesia (TD) Treatment Drugs Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type (2014-2019) (Million US$)
Table Global Tardive Dyskinesia (TD) Treatment Drugs Market Size Share by Type (2014-2019)
Figure Global Tardive Dyskinesia (TD) Treatment Drugs Market Size Market Share by Type (2014-2019)
Table Global Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application (2014-2019) (Million US$)
Table Global Tardive Dyskinesia (TD) Treatment Drugs Market Size Share by Application (2014-2019)
Figure Global Tardive Dyskinesia (TD) Treatment Drugs Market Size Market Share by Application (2014-2019)
Figure Global Tardive Dyskinesia (TD) Treatment Drugs Revenue Market Share by Application in 2018
Figure North America Tardive Dyskinesia (TD) Treatment Drugs Market Size 2014-2019 (Million US$)
Table North America Key Players Tardive Dyskinesia (TD) Treatment Drugs Revenue (2018-2019) (Million US$)
Table North America Key Players Tardive Dyskinesia (TD) Treatment Drugs Market Share (2018-2019)
Table North America Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type 2014-2019 (Million US$)
Table North America Tardive Dyskinesia (TD) Treatment Drugs Market Share by Type 2014-2019
Table North America Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application 2014-2019 (Million US$)
Table North America Tardive Dyskinesia (TD) Treatment Drugs Market Share by Application 2014-2019
Figure Europe Tardive Dyskinesia (TD) Treatment Drugs Market Size 2014-2019 (Million US$)
Table Europe Key Players Tardive Dyskinesia (TD) Treatment Drugs Revenue (2018-2019) (Million US$)
Table Europe Key Players Tardive Dyskinesia (TD) Treatment Drugs Market Share (2018-2019)
Table Europe Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type 2014-2019 (Million US$)
Table Europe Tardive Dyskinesia (TD) Treatment Drugs Market Share by Type 2014-2019
Table Europe Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application 2014-2019 (Million US$)
Table Europe Tardive Dyskinesia (TD) Treatment Drugs Market Share by Application 2014-2019
Figure China Tardive Dyskinesia (TD) Treatment Drugs Market Size 2014-2019 (Million US$)
Table China Key Players Tardive Dyskinesia (TD) Treatment Drugs Revenue (2018-2019) (Million US$)
Table China Key Players Tardive Dyskinesia (TD) Treatment Drugs Market Share (2018-2019)
Table China Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type 2014-2019 (Million US$)
Table China Tardive Dyskinesia (TD) Treatment Drugs Market Share by Type 2014-2019
Table China Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application 2014-2019 (Million US$)
Table China Tardive Dyskinesia (TD) Treatment Drugs Market Share by Application 2014-2019
Figure Japan Tardive Dyskinesia (TD) Treatment Drugs Market Size 2014-2019 (Million US$)
Table Japan Key Players Tardive Dyskinesia (TD) Treatment Drugs Revenue (2018-2019) (Million US$)
Table Japan Key Players Tardive Dyskinesia (TD) Treatment Drugs Market Share (2018-2019)
Table Japan Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type 2014-2019 (Million US$)
Table Japan Tardive Dyskinesia (TD) Treatment Drugs Market Share by Type 2014-2019
Table Japan Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application 2014-2019 (Million US$)
Table Japan Tardive Dyskinesia (TD) Treatment Drugs Market Share by Application 2014-2019
Figure Southeast Asia Tardive Dyskinesia (TD) Treatment Drugs Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Tardive Dyskinesia (TD) Treatment Drugs Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Tardive Dyskinesia (TD) Treatment Drugs Market Share (2018-2019)
Table Southeast Asia Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type 2014-2019 (Million US$)
Table Southeast Asia Tardive Dyskinesia (TD) Treatment Drugs Market Share by Type 2014-2019
Table Southeast Asia Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application 2014-2019 (Million US$)
Table Southeast Asia Tardive Dyskinesia (TD) Treatment Drugs Market Share by Application 2014-2019
Figure India Tardive Dyskinesia (TD) Treatment Drugs Market Size 2014-2019 (Million US$)
Table India Key Players Tardive Dyskinesia (TD) Treatment Drugs Revenue (2018-2019) (Million US$)
Table India Key Players Tardive Dyskinesia (TD) Treatment Drugs Market Share (2018-2019)
Table India Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type 2014-2019 (Million US$)
Table India Tardive Dyskinesia (TD) Treatment Drugs Market Share by Type 2014-2019
Table India Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application 2014-2019 (Million US$)
Table India Tardive Dyskinesia (TD) Treatment Drugs Market Share by Application 2014-2019
Figure Central & South America Tardive Dyskinesia (TD) Treatment Drugs Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Tardive Dyskinesia (TD) Treatment Drugs Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Tardive Dyskinesia (TD) Treatment Drugs Market Share (2018-2019)
Table Central & South America Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type 2014-2019 (Million US$)
Table Central & South America Tardive Dyskinesia (TD) Treatment Drugs Market Share by Type 2014-2019
Table Central & South America Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application 2014-2019 (Million US$)
Table Central & South America Tardive Dyskinesia (TD) Treatment Drugs Market Share by Application 2014-2019
Table Neurocrine Biosciences, Inc. Company Details
Table Neurocrine Biosciences, Inc. Revenue in Tardive Dyskinesia (TD) Treatment Drugs Business 2014-2019 (Million US$)
Figure Neurocrine Biosciences, Inc. Revenue Growth Rate in Tardive Dyskinesia (TD) Treatment Drugs Business (2014-2019)
Table Neurocrine Biosciences, Inc. Recent Development
Table Teva Pharmaceutical Industries Company Details
Table Teva Pharmaceutical Industries Revenue in Tardive Dyskinesia (TD) Treatment Drugs Business 2014-2019 (Million US$)
Figure Teva Pharmaceutical Industries Revenue Growth Rate in Tardive Dyskinesia (TD) Treatment Drugs Business (2014-2019)
Table Teva Pharmaceutical Industries Recent Development
Table Pfizer Inc. Company Details
Table Pfizer Inc. Revenue in Tardive Dyskinesia (TD) Treatment Drugs Business 2014-2019 (Million US$)
Figure Pfizer Inc. Revenue Growth Rate in Tardive Dyskinesia (TD) Treatment Drugs Business (2014-2019)
Table Pfizer Inc. Recent Development
Table Biogen Company Details
Table Biogen Revenue in Tardive Dyskinesia (TD) Treatment Drugs Business 2014-2019 (Million US$)
Figure Biogen Revenue Growth Rate in Tardive Dyskinesia (TD) Treatment Drugs Business (2014-2019)
Table Biogen Recent Development
Table Novartis AG Company Details
Table Novartis AG Revenue in Tardive Dyskinesia (TD) Treatment Drugs Business 2014-2019 (Million US$)
Figure Novartis AG Revenue Growth Rate in Tardive Dyskinesia (TD) Treatment Drugs Business (2014-2019)
Table Novartis AG Recent Development
Table AstraZeneca Company Details
Table AstraZeneca Revenue in Tardive Dyskinesia (TD) Treatment Drugs Business 2014-2019 (Million US$)
Figure AstraZeneca Revenue Growth Rate in Tardive Dyskinesia (TD) Treatment Drugs Business (2014-2019)
Table AstraZeneca Recent Development
Table GlaxoSmithKline plc. Company Details
Table GlaxoSmithKline plc. Revenue in Tardive Dyskinesia (TD) Treatment Drugs Business 2014-2019 (Million US$)
Figure GlaxoSmithKline plc. Revenue Growth Rate in Tardive Dyskinesia (TD) Treatment Drugs Business (2014-2019)
Table GlaxoSmithKline plc. Recent Development
Table Bayer AG Company Details
Table Bayer AG Revenue in Tardive Dyskinesia (TD) Treatment Drugs Business 2014-2019 (Million US$)
Figure Bayer AG Revenue Growth Rate in Tardive Dyskinesia (TD) Treatment Drugs Business (2014-2019)
Table Bayer AG Recent Development
Table Sanofi Company Details
Table Sanofi Revenue in Tardive Dyskinesia (TD) Treatment Drugs Business 2014-2019 (Million US$)
Figure Sanofi Revenue Growth Rate in Tardive Dyskinesia (TD) Treatment Drugs Business (2014-2019)
Table Sanofi Recent Development
Table Global Tardive Dyskinesia (TD) Treatment Drugs Market Size by Regions (Million US$) 2019-2025
Figure Global Tardive Dyskinesia (TD) Treatment Drugs Market Size Share by Regions (2019-2025)
Figure Global Tardive Dyskinesia (TD) Treatment Drugs Market Size Share by Regions in 2025
Figure North America Tardive Dyskinesia (TD) Treatment Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Europe Tardive Dyskinesia (TD) Treatment Drugs Market Size Forecast (2019-2025)(Million USD)
Figure China Tardive Dyskinesia (TD) Treatment Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Japan Tardive Dyskinesia (TD) Treatment Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Tardive Dyskinesia (TD) Treatment Drugs Market Size Forecast (2019-2025)(Million USD)
Figure India Tardive Dyskinesia (TD) Treatment Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Tardive Dyskinesia (TD) Treatment Drugs Market Size Forecast (2019-2025)(Million USD)
Table Global Tardive Dyskinesia (TD) Treatment Drugs Market Size by Product (2019-2025) (Million US$)
Figure Global Tardive Dyskinesia (TD) Treatment Drugs Market Size by Product (2019-2025)
Figure Global Tardive Dyskinesia (TD) Treatment Drugs Market Size by Product in 2025
Table Global Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application (2019-2025) (Million US$)
Figure Global Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application (2019-2025)
Figure Global Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
遅発性ジスキネジア（TD）治療薬のグローバル市場：規模・現状・予測2019-2025 Tardive dyskinesia is a type of neurological disorder, which characterized the blink your eyes fast, chew, smack or pucker of lips, puff out your cheeks, tongue and others. The patients treating with neuroleptic drugs or anti-psychotic medications can also be the cause of tardive dyskinesia. Tardive…- 副鼻腔炎治療薬のグローバル市場：規模・現状・予測2019-2025 Sinusitis is an inflammation or swelling of the tissue lining the sinuses.In 2018, the global Sinusitis Treatment Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Sinusitis Treat…
- 副鼻腔炎治療薬のグローバル市場：規模・現状・予測2019-2025 Sinusitis is an inflammation or swelling of the tissue lining the sinuses.In 2018, the global Sinusitis Treatment Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Sinusitis Treat…
- 不眠症治療薬のグローバル市場：規模・現状・予測2019-2025 Insomnia is a sleep disorder characterized by difficulty falling and/or staying asleep. Insomnia medications can improve this condition.In 2018, the global Insomnia Treatment Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during…
- 不眠症治療薬のグローバル市場：規模・現状・予測2019-2025 Insomnia is a sleep disorder characterized by difficulty falling and/or staying asleep. Insomnia medications can improve this condition.In 2018, the global Insomnia Treatment Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during…